ZimVie announced today that it completed the sale of its spine business to establish itself as a pure-play dental company. The company also shared details on the makeup of the leadership team at the now-sold business unit. The Westminster, Colorado-based ZimVie announced its intent to sell the spine business to H.I.G. Capital in December 2023. […]
ZimVie
How GLP-1s tanked and reshaped the medtech stock market in 2023
Analysts weigh in on how the GLP-1 craze caused one of the biggest swings in the medtech stock market in recent years.
In a tumultuous year for the medtech industry, the combination of strong sales growth and promising clinical trial results from glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market, triggering one of the largest dips in market value that analysts have seen in years. While analysts said the medtech stock market […]
ZimVie to sell spine business, become pure-play dental company
ZimVie announced today that it agreed to sell its spine business to investment firm H.I.G. Capital. Shares of ZIMV skyrocketed more than 50% to $17.05 apiece by the afternoon. MassDevice‘s MedTech 100 Index was up slightly. The sale of the business, valued at $375 million, establishes ZimVie as a pure-play dental company. Westminster, Colorado-based ZimVie […]
FDA clears ZimVie and Brainlab spinal fixation combo
ZimVie announced today that the FDA has cleared the use of its Vital spinal fixation system with Brainlab’s Spine & Trauma Navigation. The news comes just nine months after the companies announced a partnership in which Brainlab will provide spine imaging, planning, navigation, and robotic-assisted systems for use with ZimVie implants. The goal is to enable […]
ZimVie beats The Street in Q3, ups back end of guidance
ZimVie shares ticked up this morning on third-quarter results that topped the consensus forecast. Shares of ZIMV rose 1% at $6.80 apiece just after the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 1.1%. The (LOCATION)-based company posted losses of $5.1 million […]
First U.S. procedure performed with ZimVie 4.5mm Mobi-C device
ZimVie announced today that the first U.S. patient received its new 4.5mm Mobi-C cervical disc. Mobi-C became the first cervical disc approved for one and two levels by the FDA in 2013. Ten years later, in August of this year, ZimVie picked up FDA approval for a smaller height for the device. The updated 4.5mm […]
ZimVie reaches 2,000-child milestone for Tether system
ZimVie announced today that more than 2,000 children have been treated with the Tether vertebral body tethering system. Tether, approved as a humanitarian device by the FDA in 2019, treats skeletally immature patients. These patients require surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis. They present a major Cobb angle of 30 […]
FDA grants IDE for ZimVie Mobi-C hybrid arthroplasty, fusion study
ZimVie announced today that it received FDA investigational device exemption (IDE) to conduct a study of its Mobi-C. The study evaluates the Mobi-C cervical disc in hybrid use. Patients in the study receive simultaneous cervical disc arthroplasty (CDA) and anterior cervical discectomy and fusion (ACDF) at adjacent levels between C3 and C7. ZimVie says the […]
ZimVie expands development deal with Brainlab to include co-marketing
ZimVie announced today that it expanded its cooperation agreement with Brainlab. Brainlab offers a diversified spine imaging, planning and navigation portfolio. It also provides robotic imaging, surgical assistance and mixed reality to support spinal surgeries. Westminster, Colorado-based ZimVie and Brainlab undertook a joint project to achieve compatibility between technologies. It aims to combine ZimVie’s Vital […]
The 10 largest orthopedic device companies in the world
Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year. Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic. GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 […]
FDA grants new approval for ZimVie Mobi-C implant, plans U.S. launch in the fall
ZimVie announced today that the FDA approved a smaller height of its Mobi-C cervical disc. The updated approval covers Mobi-C in seven footprints that address the anatomical needs of patients in the U.S. Mobi-C has been used for cervical disc replacement to treat patients in France since 2004. In 2013, it became the first cervical […]